Sanfilippo syndrome
Mortality in patients with Sanfilippo syndrome
... with Sanfilippo syndrome types A and ...with Sanfilippo syndrome, the lon- gevity of patients dying from this respiratory infection has not increased ...with Sanfilippo syndrome ...
7
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
... of Sanfilippo syndrome is that the length of the follow-up period is difficult to determine because we found that the age range at diagnosis was relatively ...
11
Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data
... with Sanfilippo B is provided primar- ily by parents, but siblings, relatives, partners, or profes- sional caregivers may also provide ...in Sanfilippo B, survey findings of caregivers of Sanfilippo ...
9
Scoring Evaluation of the Natural Course of Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
... (Sanfilippo syndrome) is a genetically and clinically heterog- enous group of diseases caused by the deficiency of 1 of 4 enzymes (defining subtypes A–D) involved in the deg- radation of heparan ...
9
Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
... (Sanfilippo syndrome) comprises a group of rare, lysosomal storage diseases caused by the deficiency of one of four enzymes involved in the degradation of heparan ...
10
Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
... The mucopolysaccharide (MPS) disorders comprise a group of inherited metabolic diseases in which specific lysosomal enzymes are absent or deficient, causing cellu- lar accumulation of glycosaminoglycans (GAGs). This ...
11
Sanfilippo syndrome: causes, consequences, and treatments
... Abstract: Sanfilippo syndrome, or mucopolysaccharidosis (MPS) type III, refers to one of five autosomal recessive, neurodegenerative lysosomal storage disorders (MPS IIIA to MPS IIIE) whose symptoms are ...
13
Natural history of Sanfilippo syndrome in Spain
... or Sanfilippo syndrome, is caused by a deficiency in one of the four enzymes involved in the lysosomal degradation of heparan ...of Sanfilippo patients (MPSIIIA, MPSIIIB and MPSIIIC), representing an ...
11
Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
... Patients with the classical severe phenotype of MPS III generally reached a maximal developmental age of approximately 3-4 years (Figure 5), while patients with a more attenuated phenoty[r] ...
6
Tachypnea of Infancy as the First Sign of Sanfilippo Syndrome
... Lung growth abnormalities (including chronic lung disease of prematurity) Neuroendocrine hyperplasia of infancy Pulmonary interstitial glycogenosis Surfactant dysfunction disorders Hyper[r] ...
7
Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations
... nature of the mutation. For the treatment of donor ss mutations, U1 snRNAs could represent a feasible option. This would depend on the presence of alternative donor sites close to the normal site that could interfere ...
12
IS ATTENTION DEFICIT /HYPERACTIVITY DISORDER (ADHD) A DIAGNOSIS OR A SYMPTOM COMPLEX? EXPERIENCE FROM PEDIATRIC ORTHOPEDIC PRACTICE
... Objective: Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include hyperactivity and impulsiveness. The etiological understanding is somehow controversial. We aimed to study the ...
10
Sanfilippo type A: new clinical manifestations and neuro imaging findings in patients from the same family in Israel: a case report
... Case presentation: Two daughters (13 and 11 years old) of a consanguineous Palestinian family from the Israeli Arab community were investigated clinically and genetically for the presence of progressive neurodegenerative ...
6
Determining the sensory needs of children with Hunter and Sanfilippo syndromes who need hospital treatment
... Sanfilippo syndrome (mucopolysaccharidoses MPS III) is an inherited, autosomal recessive, metabolism disorder that where the body is unable to effectively break down long chains of sugar molecules called ...
31
New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
... with Sanfilippo Syndrome type A (MPS IIIA) initially showed clinical safety, albeit in the presence of antibody formation and decline of CSF heparan sulfate levels [26], but after a phase IIb trial this ...
9
A Study on Diseases Affecting Litopenaeus vannamei Farming in Coastal Districts of Andhra Pradesh, India
... Enterocytozoon hepatopenaei (EHP), observed in Mainly in Krishna district, less in Guntur than Krishna district also observed equal in West Godavari and East Godavari district, EHP is a microsporidian caused by parasite ...
6
Download Download PDF
... vasoconstriction syndrome (RCVS) should also be mentioned as an important differential diag- ...clinical-angiographic syndrome that occurs usually in women and is manifested by sudden attacks of severe ...
7
Significance of defecography and the role of rectocele in constipated patients
... Anorectal outlet obstruction is a form of chronic con- stipation in which pan-colonic transit time is normal but there is delayed transit in the rectosigmoid segment. Some of these patients have dilatation of the rectum ...
5
Comorbidity of the Metabolic Syndrome: Hyperuricemia, Gallstone Disease, Hormonal Disorders
... reduces levels of endothelial nitric oxide (NO), a key mediator of insulin action. NO increases blood flow to skeletal muscle and enhances glucose uptake, thereby its deficiency causes insulin resistance and other ...
9
The expanding spectrum of rare monogenic autoinflammatory diseases
... Blau syndrome, and Pyogenic sterile Arthritis, Pyoderma gangrenosum and Acne (PAPA) syndrome, have been extensively reviewed since the concept of autoinflammation was created in 1999 ...
12